2021 North Kivu Ebola
2021 North Kivu Ebola Outbreak[edit | edit source]
The 2021 North Kivu Ebola outbreak was a resurgence of the Ebola virus disease in the Democratic Republic of the Congo (DRC), specifically in the North Kivu province. This outbreak was declared on February 7, 2021, and was linked to the 2018–2020 Kivu Ebola epidemic.
Background[edit | edit source]
The Democratic Republic of the Congo has experienced multiple Ebola outbreaks since the virus was first discovered in 1976. The Kivu Ebola epidemic from 2018 to 2020 was one of the largest and most complex, affecting the North Kivu and Ituri provinces. The region's ongoing conflict and instability have posed significant challenges to public health efforts.
Outbreak[edit | edit source]
The 2021 outbreak was declared after a woman from the Biena Health Zone in North Kivu tested positive for the Ebola virus. She was the wife of an Ebola survivor from the previous outbreak. The outbreak was quickly contained due to the rapid response by health authorities and the use of vaccination strategies.
Response[edit | edit source]
The response to the outbreak involved a coordinated effort by the World Health Organization (WHO), the DRC Ministry of Health, and various international partners. Vaccination campaigns were swiftly implemented, targeting contacts and contacts of contacts of confirmed cases. The use of the rVSV-ZEBOV vaccine was instrumental in controlling the spread of the virus.
Challenges[edit | edit source]
The response faced several challenges, including community mistrust, logistical difficulties, and the ongoing conflict in the region. Health workers had to navigate these issues while ensuring the safety and effectiveness of the response efforts.
Conclusion[edit | edit source]
The outbreak was declared over on May 3, 2021, after no new cases were reported for 42 days. The rapid containment of the outbreak was attributed to the lessons learned from previous outbreaks and the effective use of vaccination and surveillance strategies.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD